Based on these results, the decrease in the proportion of B1 cells in the peripheral blood of patients with DCM is closely related to the increased levels of β1-AR autoantibodies, indirectly suggesting that the decrease in the proportion of B1 cells in peripheral blood may increase the incidence of heart failure and mortality in patients with DCM. This evidence concerns the gene ADRB1 and familial dilated cardiomyopathy.